Yifeng Pharmacy Chain Co., Ltd. (603939.SS)
CNY 25.67
(-0.62%)
CNY 25.67
(-0.62%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.41 Billion CNY | 11.9% |
| 2022 | 1.26 Billion CNY | 42.12% |
| 2021 | 887.88 Million CNY | 19.42% |
| 2020 | 743.52 Million CNY | 36.74% |
| 2019 | 543.75 Million CNY | 30.58% |
| 2018 | 416.41 Million CNY | 32.83% |
| 2017 | 313.5 Million CNY | 40.03% |
| 2016 | 223.89 Million CNY | 27.26% |
| 2015 | 175.93 Million CNY | 25.17% |
| 2014 | 140.56 Million CNY | 41.71% |
| 2013 | 99.18 Million CNY | 44.58% |
| 2012 | 68.6 Million CNY | 22.77% |
| 2011 | 55.87 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 390.96 Million CNY | -3.88% |
| 2024 Q3 | 312.78 Million CNY | -20.0% |
| 2024 Q1 | 406.75 Million CNY | -1.47% |
| 2023 Q2 | 368.67 Million CNY | 9.57% |
| 2023 Q1 | 336.47 Million CNY | -23.88% |
| 2023 FY | 1.41 Billion CNY | 11.9% |
| 2023 Q4 | 412.8 Million CNY | 40.39% |
| 2023 Q3 | 294.03 Million CNY | -20.25% |
| 2022 Q4 | 442.01 Million CNY | 78.83% |
| 2022 Q3 | 247.17 Million CNY | -18.75% |
| 2022 Q2 | 304.19 Million CNY | 11.74% |
| 2022 Q1 | 272.22 Million CNY | 41.84% |
| 2022 FY | 1.26 Billion CNY | 42.12% |
| 2021 Q2 | 263.45 Million CNY | 9.18% |
| 2021 FY | 887.88 Million CNY | 19.42% |
| 2021 Q1 | 241.29 Million CNY | 35.72% |
| 2021 Q3 | 191.2 Million CNY | -27.42% |
| 2021 Q4 | 191.92 Million CNY | 0.38% |
| 2020 Q2 | 221.41 Million CNY | 18.73% |
| 2020 Q3 | 178.21 Million CNY | -19.51% |
| 2020 Q4 | 177.78 Million CNY | -0.24% |
| 2020 FY | 743.52 Million CNY | 36.74% |
| 2020 Q1 | 186.49 Million CNY | 48.67% |
| 2019 Q4 | 125.43 Million CNY | 13.74% |
| 2019 Q1 | 147.16 Million CNY | 36.7% |
| 2019 FY | 543.75 Million CNY | 30.58% |
| 2019 Q2 | 160.85 Million CNY | 9.3% |
| 2019 Q3 | 110.28 Million CNY | -31.44% |
| 2018 Q4 | 107.65 Million CNY | 28.84% |
| 2018 FY | 416.41 Million CNY | 32.83% |
| 2018 Q3 | 83.55 Million CNY | -32.75% |
| 2018 Q2 | 124.24 Million CNY | 23.07% |
| 2018 Q1 | 100.95 Million CNY | 8.19% |
| 2017 FY | 313.5 Million CNY | 40.03% |
| 2017 Q1 | 69.35 Million CNY | 7.48% |
| 2017 Q2 | 85.44 Million CNY | 23.2% |
| 2017 Q3 | 65.38 Million CNY | -23.47% |
| 2017 Q4 | 93.31 Million CNY | 42.72% |
| 2016 Q2 | 59.82 Million CNY | 14.44% |
| 2016 Q3 | 47.26 Million CNY | -21.0% |
| 2016 Q4 | 64.52 Million CNY | 36.52% |
| 2016 FY | 223.89 Million CNY | 27.26% |
| 2016 Q1 | 52.27 Million CNY | 3.16% |
| 2015 Q4 | 50.67 Million CNY | 35.55% |
| 2015 Q3 | 37.38 Million CNY | -20.03% |
| 2015 Q2 | 46.75 Million CNY | 13.68% |
| 2015 Q1 | 41.12 Million CNY | -6.47% |
| 2015 FY | 175.93 Million CNY | 25.17% |
| 2014 Q1 | 32.1 Million CNY | 0.0% |
| 2014 FY | 140.56 Million CNY | 41.71% |
| 2014 Q4 | 43.96 Million CNY | 50.91% |
| 2014 Q3 | 29.13 Million CNY | -17.58% |
| 2014 Q2 | 35.34 Million CNY | 10.1% |
| 2013 FY | 99.18 Million CNY | 44.58% |
| 2012 FY | 68.6 Million CNY | 22.77% |
| 2011 FY | 55.87 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 89.27 Million CNY | -1481.609% |
| Jointown Pharmaceutical Group Co., Ltd | 2.17 Billion CNY | 35.053% |
| LBX Pharmacy Chain Joint Stock Company | 929.02 Million CNY | -51.986% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 414.41 Million CNY | -240.721% |